ClinicalTrials.govpublic full text
IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
pancreatic cancer, borderline resectable pancreatic adenocarcinoma, claudin 18.2 positive, neoadjuvant therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 967982
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.